What Researchers Did
Researchers reviewed how hyperbaric oxygen therapy (HBOT) helps fight infections and its use in treating specific infectious diseases.
What They Found
They found that HBOT acts as an anti-infective agent, either as a primary or additional treatment for conditions like gas gangrene, necrotizing fasciitis, diabetic foot infections, and refractory osteomyelitis. HBOT works by increasing oxygen radicals to fight anaerobic bacteria, enhancing the immune system's ability to kill bacteria in low-oxygen wounds, and working together with antibiotics.
What This Means for Canadian Patients
For Canadian patients suffering from severe infections like diabetic foot infections, necrotizing fasciitis, or refractory osteomyelitis, this review suggests HBOT could be a valuable treatment option. It highlights HBOT's potential to improve outcomes by directly fighting bacteria, boosting the body's immune response, and enhancing antibiotic effectiveness.
Canadian Relevance
This study covers several conditions, including gas gangrene, necrotizing fasciitis, diabetic foot infections, and refractory osteomyelitis, which are recognized by Health Canada as indications for hyperbaric oxygen therapy.
Study Limitations
As a review article, this study synthesizes existing literature but does not present new experimental data or patient outcomes from a controlled trial.